insights_auto
Why is ARGX down ၄.၀၉%?
Dive Deeperchevron_right
ARGX:EBR
argenx SE
၇၂၇.၆၀ €
arrow_downward
-၄.၀၉%(-၃၁.၀၀) 1D
အောက် ၁၆, GMT+၂ ၁၇:၃၉:၃၅ · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARGX...
Open
၇၅၉.၂၀ €
High
၇၆၁.၈၀ €
Low
၇၂၇.၆၀ €
Mkt. cap
ဋေ ၄.၈၄ ထ
Avg. vol.
၈.၆၉ သောင်း
Volume
၉.၆၂ သောင်း
P/E ratio
၃၀.၉၅
52-wk high
၉၂၅.၀၀ €
52-wk low
၅၆၈.၄၀ €
EPS
၂၃.၅၁ €
Shares outstanding
၃.၅၉ ကုဋေ
No. of employees
၂ ထောင်
Open
၇၅၉.၂၀ €
High
၇၆၁.၈၀ €
Low
၇၂၇.၆၀ €
Mkt. cap
ဋေ ၄.၈၄ ထ
Avg. vol.
၈.၆၉ သောင်း
Volume
၉.၆၂ သောင်း
P/E ratio
၃၀.၉၅
52-wk high
၉၂၅.၀၀ €
52-wk low
၅၆၈.၄၀ €
EPS
၂၃.၅၁ €
Shares outstanding
၃.၅၉ ကုဋေ
No. of employees
၂ ထောင်
News stories
From web sources and news partners
ad-hoc-news.de
·
ပြီးခဲ့သည့် ၁ ရက်
argenx reports trial results: what it means for argenx stock
TipRanks
·
ပြီးခဲ့သည့် ၂ ရက်
Argenx Stock Stumbles As Trial Failure Haunts Rally
Yahoo Finance
·
ပြီးခဲ့သည့် ၂ ရက်
Zacks Investment Ideas feature highlights: Cummins, Argenx and PACCAR
Profile
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
About argenx SE